These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Xanthelasma palpebrarum treatment with a 1,450-nm-diode laser. Park EJ; Youn SH; Cho EB; Lee GS; Hann SK; Kim KH; Kim KJ Dermatol Surg; 2011 Jun; 37(6):791-6. PubMed ID: 21605240 [TBL] [Abstract][Full Text] [Related]
28. Surgical Treatment as a First Option of the Lower Eyelid Xanthelasma. Obradovic B J Craniofac Surg; 2017 Oct; 28(7):e678-e679. PubMed ID: 28857993 [TBL] [Abstract][Full Text] [Related]
29. Treatment of xanthelasma palpebrarum with the pulsed dye laser. Schönermark MP; Raulin C Lasers Surg Med; 1996; 19(3):336-9. PubMed ID: 8923429 [TBL] [Abstract][Full Text] [Related]
30. Treatment of xanthelasma palpebrarum with intralesional heparin sodium: a pilot study. Azendour H; Alami S; Meziane M; Ismaili N; Benzekri L; Senouci K Int J Dermatol; 2023 Mar; 62(3):e124-e125. PubMed ID: 36371701 [No Abstract] [Full Text] [Related]
32. New operative technique for treatment of xanthelasma palpebrarum: laser-inverted resurfacing: preliminary report. Levy JL; Trelles MA Ann Plast Surg; 2003 Apr; 50(4):339-43. PubMed ID: 12671372 [TBL] [Abstract][Full Text] [Related]
33. Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: A systematic review and meta-analysis. Chang HC; Sung CW; Lin MH J Am Acad Dermatol; 2020 Mar; 82(3):596-605. PubMed ID: 31499151 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of trichloroacetic acid (95%) in the management of xanthelasma palpebrarum. Cannon PS; Ajit R; Leatherbarrow B Clin Exp Dermatol; 2010 Dec; 35(8):845-8. PubMed ID: 20456397 [TBL] [Abstract][Full Text] [Related]